top of page
SpeeDx_DNA.png

Trusted by industry leaders worldwide

cepheid.png
gsk.jpeg
BIOCARTIS_edited.png
labcorp.png

Global Leader in Molecular Multiplexing Diagnostics 

Smart, cost-effective technologies enabling multiplexing on your platform without compromising on performance 

15+ years of innovation

Molecular Multiplexing

Our proprietary technologies deliver. Whether you need high specificity, reliable mutation differentiation, or very high multiplexing capabilities — the solution is SpeeDx.  

STI Diagnostics

With over a decade of excellence, our STI diagnostic solutions continue to set industry standards for accuracy, specificity, and resistance identification, empowering clinicians to advance clinical outcomes.

Bespoke Product Development

Partner with our expert team to develop custom solutions tailored to your specific requirements, leveraging our proven development process. 

Molecular Multiplexing

Our proprietary technologies deliver. Whether you need high specificity, reliable mutation differentiation, or very high multiplexing capabilities – the solution is SpeeDx.  

STI Innovation

With over a decade of experience, our STI solutions identifying key organisms and informing on antibiotic resistance markers, will help drive your next clinical research project. View our Product Portfolio.

Bespoke Product Development

Partner with our expert team to develop custom solutions tailored to your specific requirements, leveraging our proven development process. 

Multiplexing Prowess

With 15+ years of multiplexing innovation, SpeeDx patented technologies exceed laboratory expectations. The PlexZyme® is the foundation for multiplexing across all of our technologies delivering high sensitivity, while novel mutation amplification with PlexPrime® technology achieves great specificity for single and complex clustered mutations. 

Our latest innovation, PlexPlus® technology, achieves unparalleled multiplexing capabilities, through simultaneous real-time detection across multiple targets in each channel. 

  • Improve laboratory efficiency

  • Significantly reduce testing costs 

  • Decrease time-to-result 

Gemini_Generated_Image_phr75iphr75iphr7.png

Partnership Services

Flexible partnering options

Customized agreements to meet your business needs

Accelerated development timelines

Leverage our expertise to bring products to market faster

Manufacturing scale-up support

End-to-end production assistance for seamless growth

Solutions for Reference Labs

Cost-effective reagents

Single-well multiplexing for less

Comprehensive training and support

Expert technical assistance throughout implementation

Validated on major molecular platforms

Compatible with your existing laboratory equipment

Partnership Services

Flexible partnering options

Customized agreements to meet your business needs

Accelerated development timelines

Leverage our expertise to bring products to market faster

Manufacturing scale-up support

End-to-end production assistance for seamless growth

Our Product Portfolio

Comprehensive range of molecular diagnostic solutions designed to meet the evolving clinical and research needs of laboratories.

Multiplexed IVD Products

Advanced panels simultaneously detect relevant diagnostic targets.  
 

  • Detect infecting organisms along with antimicrobial resistance markers 

  • Provide prompt analysis of typical respiratory viruses

  • Uncover syphilis cases with our lesions panel

Targeted Research Assays

Multiplexed solutions identifying key pathogens for infectious disease research.

  • Flexible solutions detecting bacteria, viruses, and parasites contributing to gastrointestinal illness

  • Panels for detection of common fungi causing dermatophytosis

  • Expanded target selection for STIs, respiratory, or lesions

Custom Research Assays

Targeted panels for your specific research needs, delivered through innovative multiplexing technologies.

  • Custom target combinations

  • Specialized applications

  • Advanced multiplexing capabilities

Our Product Portfolio

Comprehensive range of molecular diagnostic solutions designed to meet the evolving research needs of laboratories.

Sexually Transmitted Infections

Multiplexed solutions identifying key pathogens associated with STIs.  

  • Multiple target panels

  • AMR markers associated with GC and MG

  • Open platform workflow

Respiratory

A variety of panels for accurate identification of respiratory pathogens.

  • Reliable target differentiation

  • Scalable sample throughput

  • Cost-effective reagents

Enteric

Flexible solutions detecting bacteria, viruses, and parasites contributing to gastrointestinal illness.

  • Comprehensive pathogen detection

  • Mini panels for a modular approach

  • Seamless workflow integration

Custom Research Assays

Targeted panels for your specific research needs, delivered through innovative multiplexing technologies.

  • Custom target combinations

  • Specialized applications

  • Advanced multiplexing capabilities

Our Services

From initial concept to commercial readiness, our development services team deliver comprehensive support for customized solutions. With expertise spanning assay design, regulatory strategy, and manufacturing scale-up, we transform your testing challenges into market-ready products—faster and more cost-effectively than building in-house capabilities. 

Technology Partnering

For any industry — Access proprietary multiplexing technologies to enhance your capabilities. 

Custom Development

For laboratories — Solutions tailored to your specific needs and platform requirements. 

Strategic Collaboration

For diagnostic companies — Combine our expertise to enhance your commercial diagnostic offering. 

Co-Development

For biotechs & pharma — Capitalize on our unique technologies to develop CDx or complementary diagnostics, and more. 

The SpeeDx Partnership Advantage

Experience the difference of partnering with the established leader in molecular multiplexing technology.

Features

SpeeDx

Competitors

Development Timeline

Accelerated development timelines through proven multiplexing expertise

Standard

Cost Effective Solutions

Optimized assay development reduces overall project costs

Market Average

Multiplexing Capabilities

2 readouts per channel Achieve up to 12+ targets per well

3-5 targets per well

Regulatory Experience

Proven track record in navigating complex regulatory landscapes

Limited Regions

Ready to Transform Your Testing Capabilities?

Discover how SpeeDx's innovative multiplexing technologies can enhance your laboratory efficiency or propel your company forward.

Organisation type
Diagnostic / Reference Laboratory
Diagnostic Company
Instrument or POC Device Manufacturer
Pharma Company
Biotech Company
Other

*SpeeDx is a global company, operating in compliance with privacy regulations or laws, including, but not limited to; General Data Protection Regulation (EU), HIPAA (USA) and Australian Privacy Law (AU).

bottom of page